# FDA Inspection 1067650 - ImpactLife - September 13, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/impactlife/bf6c9abb-4390-4c1c-bc9d-b1de7e34e7d1
Source feed: FDA_Inspections

> FDA Inspection 1067650 for ImpactLife on September 13, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067650
- Company Name: ImpactLife
- Inspection Date: 2018-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1229492 - 2024-08-15](https://www.globalkeysolutions.net/records/fda_inspections/impactlife/06d14284-ce65-4d35-a990-f381f392eccf)
- [FDA Inspection 985189 - 2016-09-13](https://www.globalkeysolutions.net/records/fda_inspections/impactlife/b315a1c1-0221-40f8-b12f-4d7eec1cc22e)
- [FDA Inspection 872311 - 2014-03-31](https://www.globalkeysolutions.net/records/fda_inspections/impactlife/367e90d6-5441-4f66-ba02-0b77752daab0)
- [FDA Inspection 664891 - 2010-06-03](https://www.globalkeysolutions.net/records/fda_inspections/impactlife/cf7925de-3537-441a-ac8d-90afe0a63178)

Company: https://www.globalkeysolutions.net/companies/impactlife/b8c9a85e-a0cc-41d6-809f-2c15c7ffa505

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d